1. Clinical Overview
Metformin + Glimepiride is a potent, synergistic, oral fixed-dose combination (FDC) antidiabetic medication used for the management of type 2 diabetes mellitus (T2DM) in patients inadequately controlled on either monotherapy. Metformin, a biguanide, primarily reduces hepatic glucose production and improves insulin sensitivity. Glimepiride, a sulfonylurea (third-generation), stimulates insulin secretion from pancreatic beta cells. This combination addresses both insulin resistance and insulin deficiency, offering a comprehensive approach to glycemic control. It is a cornerstone therapy in the Indian diabetes management algorithm, especially for patients with HbA1c > 8.5%.
| Onset | Duration | Bioavailability |
|---|---|---|
| Glimepiride: 1-2 hours; Metformin: Variable, primary effect within days. | Glimepiride: Up to 24 hours (allowing once-daily dosing); Metformin: 12-24 hours. | Metformin: 50-60%; Glimepiride: ~100%. |
2. Mechanism of Action
The combination exerts a dual mechanism: Metformin decreases hepatic gluconeogenesis and glycogenolysis, increases peripheral glucose uptake and utilization (improving insulin sensitivity), and delays intestinal absorption of glucose. Glimepiride binds to sulfonylurea receptors (SUR1) on pancreatic beta-cell membranes, leading to closure of ATP-sensitive potassium channels, membrane depolarization, calcium influx, and subsequent exocytosis of insulin granules.
3. Indications & Uses
- Type 2 Diabetes Mellitus (as second-line therapy in patients inadequately controlled on monotherapy with either metformin or a sulfonylurea)
- Management of hyperglycemia in T2DM when diet and exercise plus a single agent do not provide adequate glycemic control.
4. Dosage & Administration
Adult Dosage: Individualized. Common starting strength: Metformin 500 mg + Glimepiride 1 mg or 2 mg once or twice daily with meals. Maximum daily dose: Metformin 2000 mg + Glimepiride 4 mg (or as per specific brand limits). Dose titration should be at 1-2 week intervals.
Administration: Take with or immediately after main meals to reduce gastrointestinal side effects (from metformin) and minimize risk of hypoglycemia. Swallow whole with a glass of water. Do not crush or chew. Maintain regular meal patterns.
5. Side Effects
Common side effects may include:
- Hypoglycemia (due to glimepiride)
- Nausea
- Diarrhea
- Vomiting
- Abdominal discomfort
- Flatulence
- Headache
- Dizziness
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Other Antidiabetics (Insulin, DPP-4 inhibitors, etc.) | Increased risk of hypoglycemia | Major |
| Beta-blockers (e.g., Propranolol) | Masked hypoglycemic symptoms (tachycardia); may potentiate hypoglycemia | Moderate |
| Alcohol | Increased risk of lactic acidosis (metformin) and potentiation of hypoglycemia (glimepiride); disulfiram-like reaction | Major |
| Corticosteroids (e.g., Prednisolone) | Decreased hypoglycemic effect; loss of glycemic control | Moderate |
| Diuretics (Thiazides, Loop diuretics) | May cause hyperglycemia; risk of lactic acidosis with metformin if dehydration occurs | Moderate |
| Warfarin | Glimepiride may potentiate warfarin effect (increased INR) | Moderate |
| CYP2C9 Inhibitors (e.g., Fluconazole, Amiodarone) | Increased glimepiride plasma levels → hypoglycemia risk | Moderate |
| CYP2C9 Inducers (e.g., Rifampicin) | Decreased glimepiride plasma levels → hyperglycemia | Moderate |
| Cationic Drugs (e.g., Cimetidine, Ranitidine) | Competition for renal tubular secretion → increased metformin levels | Moderate |
| Iodinated Contrast Media | Risk of lactic acidosis and acute renal failure. Metformin must be withheld before and after procedure. | Major |
7. Patient Counselling
- DO take the medicine with or immediately after meals.
- DO monitor your blood glucose levels regularly as advised by your doctor.
- DO maintain a regular diet and exercise schedule.
- DO inform all your doctors and surgeons that you are on this medication, especially before any surgery or radiological procedure with contrast dye.
- DONT skip meals after taking the medicine.
- DONT consume alcohol in any form.
- DONT take a double dose if you miss one. Take the next dose at the scheduled time.
- DONT start any new medicine (including OTC, herbal) without consulting your doctor.
8. Toxicology & Storage
Overdose: Primarily manifests as HYPOGLYCEMIA: sweating, trembling, anxiety, blurred vision, hunger, palpitations, confusion, seizures, loss of consciousness, coma. Lactic acidosis symptoms (with metformin overdose): vomiting, abdominal pain, hyperventilation, lethargy, coma.
Storage: Store below 30°C. Protect from light and moisture. Keep the blister strips/container tightly closed. Keep out of reach of children. Do not use after the expiry date printed on the pack.